SETD7 is a novel therapeutic target for multiple myeloma with t(11;14)+
Jiro Kikuchi(Jichi Medical University), Hideki Nakasone(Jichi Medical University)
Cited by 0
Related Papers
Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma
|Blood|2010|130
E2F-6 Suppresses Growth-Associated Apoptosis of Human Hematopoietic Progenitor Cells by Counteracting Proapoptotic Activity of E2F-1
|Stem Cells|2007|27
Homopiperazine Derivatives as a Novel Class of Proteasome Inhibitors with a Unique Mode of Proteasome Binding
|PLoS ONE|2013|16
Soluble SLAMF7 is generated by alternative splicing in multiple myeloma cells
|Haematologica|2024|2